Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature.

BMC research notes - 30 Oct 2013

Cacopardo Bruno, Benanti Francesco, Pinzone Marilia Rita, Nunnari Giuseppe

Abstract excerpt

BACKGROUND: The combination of Pegylated Interferon-alpha (PEG-IFN-α) and ribavirin is the current standard of care for the treatment of HCV infection. Unfortunately, IFN-α may lead to the induction or exacerbation of autoimmune diseases, such as psoriasis, thyroiditis, systemic lupus erythematosus and, rarely, rheumatoid arthritis (RA). CASE PRESENTATION: We report the case of a man affected with chronic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arthritis, Rheumatoid
Share to Autoantibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Peptides, Cyclic

Share to Polyethylene Glycols

Share to Ribavirin

Source

Open in PubMed Open full text

Identifiers

PMID: 24171974
DOI: 10.1186/1756-0500-6-437
PMCID: PMC3815306

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature.PMID 24171974Read ↗

Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection.Semantic proximity Read ↗

Direct antiviral drugs in the treatment of hepatitis C-infected rheumatoid arthritis Egyptian cohort: safety and clinical impact.Semantic proximity Read ↗

Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians.Semantic proximity Read ↗

[Hip joint synovitis associated with daclatasvir plus asunaprevir combination therapy to treat chronic HCV infection in elderly patients: a case report].Semantic proximity Read ↗

Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjögren's syndromeSemantic proximity Read ↗

Ulcerative colitis coexisting with hepatitis C: A rare occurrence.Semantic proximity Read ↗

Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia.Semantic proximity Read ↗

Hepatitis C virus seroprevalence and genotypes in patients with diffuse connective tissue diseases and spondyloarthropathies.Semantic proximity Read ↗

Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis.Semantic proximity Read ↗

Can hepatitis C virus infection and interferon-alpha undo the HLA-DRB1*0402/DQB1*0302 protection against rheumatoid arthritis?Semantic proximity Read ↗

Human platelet antigen-3 polymorphism as a risk factor for rheumatological manifestations in hepatitis C.Semantic proximity Read ↗

Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.